期刊文献+

白内障临床路径变异因素分析及整改措施 被引量:1

Analysis and rectification measures on variations in the clinical pathway of cataract
下载PDF
导出
摘要 目的:分析导致年龄相关性白内障临床路径变异的因素,针对性制定整改措施,提高医疗质量。方法:回顾性调查及分析我2017年6月—2018年1月年龄相关性白内障患者552例,找出发生临床变异的病例,归纳统计变异的类型及例数,提出针对性整改措施。结果:552例患者变异总数229例,变异率41.49%;总变异次数260次,变异退出53例。结论:年龄相关性白内障患者临床路径变异率较高,导致变异的主要因素是疾病因素,及时有效的分析并制定整改措施,有利于减少临床路径的变异,提高临床工作效率。 Objective To improve the level of medical quality by analyzing the variations in clinical pathway of agerelated Cataract and formulating corrective measures.Methods Make a retrospective investigation and analysis of 552cases of patients with age-related cataract between June 2017 and January 2018,identify cases of clinical variation,make a statistical inference abouttypes and numbers of the variation,propose targeted rectification measures.Results Variation in the number of cases of clinical pathways for the 552 cases,the variation rate of 41.49%,total variation is 260 times,53 cases are drawn.Conclusions The incidence of clinical pathways ishigh in patients with age-related cataract,the main cause of variation is disease,analyzing and formulating corrective actionstimely and effectivelyis beneficial to reduce the variation rate of clinical pathway and improve the clinical efficiency.
作者 刘旋娥 高翔 Liu Xuane;Gao Xiang(Department of Ophthalmology,Sun Yat-sen Memorial Hospital of Sun Yat-sen University,Guangzhou,Guangdong 510120,China)
出处 《影像研究与医学应用》 2019年第21期7-9,共3页 Journal of Imaging Research and Medical Applications
关键词 白内障 临床路径 变异 Cataract Clinical pathway Variation
  • 相关文献

参考文献5

二级参考文献44

  • 1赵杰刚,阿部俊子.日本临床路径实施概况及护理文件模式[J].中华护理杂志,2004,39(5):391-393. 被引量:38
  • 2李亚平.临床路径中的变异研究[J].中华护理杂志,2004,39(11):859-860. 被引量:75
  • 3马丽和,刘晓英.临床路径的变异研究进展[J].护理研究(上旬版),2006,20(5):1142-1144. 被引量:36
  • 4Cheah J.Development and implementation of a clinical pathway programme in an acute care general hospital in Singapore.Int J Qual Health Care, 2000,12(5):403-412.
  • 5Hyett KL, Podosky M, Santarnaria N,et al.Valuing variance:the importance of variance analysis in clinical pathway utilisation.Au Health Rev, 2007,31(4):565-570.
  • 6Dalton P, Macintosh DJ, Pearson B. Variance analysis in clinical pathways for total hip and knee joint arthroplasty. J Qual Clin Pract,2000(20) :145-149.
  • 7Verdu A, Maestre A, L6pez P, et al.Clinical pathways as a healthcare and assessment of a clinical pathway for lower- extremity deep venous thrombosis.Qual Saf Health Care,2009(18) : 314-320.
  • 8Bower KA.Clinical pathways:12 lessons learned over 25 years of experience.J Integr Care Pathw,2009 (13) :78-81.
  • 9Okita A,Yamashita M,Abe K,et al. Variance analysis of a clinical pathway of video-assisted lobectomy for lung cancer.Surg Today.2009,39(2) :104-109.
  • 10Every NR,Hochman J,Becker R,et al.Critical pathways:a riview.Circulation,2000(101):461-465.

共引文献45

同被引文献6

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部